近年来随着生殖医学理论和技术的进步,推动着临床治疗不断发展,根据患者卵巢储备功能的检测指标来评估卵巢反应性,选择个体化控制性超促排卵(i COS)方案和药物,提高治疗的精准性,可以避免过度治疗和不当治疗。关于i COS的研究和实践越来越被推崇,在2016年欧洲人类生殖与胚胎学会(ESHRE)年会上,就个体化促排卵的评估指标和方案药物,多位国际知名教授阐述了最新研究进展 In recent years, with the progress of reproductive medicine theory and technology, clinical treatment is being promoted. Ovarian response is evaluated according to the detection indexes of ovarian reserve function of patients, and individualized controlled iox programs and drugs are selected to improve The accuracy of treatment can prevent over-treatment and inappropriate treatment. As the research and practice of i COS is increasingly being promoted, at the annual meeting of the European Society for Human Reproduction and Embryology (ESHRE) 2016, a number of internationally renowned professors elaborated the latest research on individualized assessment indicators and programs for ovulation induction progress